A large-scale study by the Institute of Genomics at the University of Tartu suggests that medications taken years ago may still be detectable in the gut microbiome. By analyzing stool samples and prescription histories from more than 2,500 participants in the Estonian Biobank’s Estonian Microbiome Cohort, researchers found that many commonly prescribed drugs were associated with lasting changes in gut bacteria, including changes that remained detectable long after treatment ended.
Medications beyond antibiotics can affect the microbiome
The gut microbiome is the community of bacteria and other microorganisms living in the digestive tract. It contributes to digestion, immune function and overall health. While antibiotics are well known to disrupt gut bacteria, the study suggests that their effects are not unique among medications.
Antidepressants, beta-blockers, proton pump inhibitors and benzodiazepines were all associated with differences in the gut microbiome. Beta-blockers are commonly prescribed for high blood pressure and certain heart conditions. Proton pump inhibitors reduce stomach acid and are often used to treat acid reflux. Benzodiazepines are frequently prescribed for anxiety, while antidepressants can help manage depression and other mental health conditions.
“Most microbiome studies only consider current drugs, but our results show that past drug use may be just as important as a surprisingly strong factor in explaining differences in individual microbiomes,” said lead author Dr. Oliver Asmets.
The findings suggest that a person’s current medication list may not capture the full history relevant to their gut health. Previous treatments may help explain why the composition of gut bacteria differs substantially between individuals.
Some anxiety medications showed antibiotic-like effects
One of the study’s most notable findings involved benzodiazepines, a class of drugs commonly used to treat anxiety disorders. The researchers found that benzodiazepine use was associated with changes in the gut microbiome comparable to those linked to broad-spectrum antibiotics, which target a wide range of bacteria and can significantly alter the microbial community in the digestive system.
Drugs within the same class did not necessarily have identical effects. Diazepam and alprazolam are both benzodiazepines used for similar conditions, but the study found that they appeared to differ in the strength of their effects on gut bacteria.
This suggests that microbiome effects may depend not only on a drug class, but also on the specific medication.
Microbiome changes were observed after starting or stopping treatment
To examine whether medications were contributing to the microbial changes, the researchers collected additional stool samples from a smaller group of participants. By tracking how the microbiome changed when people started or stopped taking certain drugs, they identified predictable shifts in gut bacteria.
These results provided additional evidence that the medications themselves contributed to the changes, rather than merely being associated with pre-existing differences between patients.
Although the follow-up analysis involved relatively few participants, it showed sustained effects associated with several drug categories. These included proton pump inhibitors, selective serotonin reuptake inhibitors and certain antibiotics, including penicillin and macrolide combinations.
Selective serotonin reuptake inhibitors, or SSRIs, are a widely prescribed class of antidepressants. Macrolide antibiotics are used to treat a variety of bacterial infections.
Past prescriptions may affect microbiome research
The findings have implications for studies examining links between gut bacteria and disease. Microbiome differences may reflect not only a person’s current health and medication use, but also treatments received years earlier.
If researchers do not account for previous medications, they could incorrectly attribute differences in particular microorganisms to disease or another health factor when earlier drug exposure may have contributed.
The study also underscores how much remains unknown about the long-term relationship between medications and the gut microbiome. Although the researchers identified persistent microbial changes, the results do not show that these changes are necessarily harmful or that they cause specific health problems.
“This is a comprehensive, systematic evaluation of long-term drug effects on the microbiome using real medical health records,” said corresponding author Professor Erin Oog. “We hope this will encourage researchers and clinicians to take drug history into account when interpreting microbiome data.”
Source: www.sciencedaily.com


